http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2015, Vol. 24 ›› Issue (12): 780-788.DOI: 10.5246/jcps.2015.12.100

• Original articles • Previous Articles     Next Articles

Bioavailability of 10-hydroxycamptothecin-phospholipid complex loaded by solid dispersion and lipid-based formulations

Xianchuang Wu1, Haijun Hao2, Yuxin Liu1, Xiaoyong Song1*, Yongzhou Zhang1, Hongqin Zhang3   

  1. 1. Department of Pharmacy, Huai He Hospital of Henan University, Kaifeng 475000, China
    2. Shanghai Institute of Pharmaceutical Industry, Shanghai 200437, China
    3. Shanghai Advanced Vehicle Technology Pharmaceutical L.T.D. Co, Shanghai 201203, China
  • Received:2015-07-07 Revised:2015-09-01 Online:2015-12-22 Published:2015-09-30
  • Contact: Tel.: 0371-23906970, E-mail: sxyyjk@sina.com
  • Supported by:
    Science and Technology Department of Henan province Fund Project (Grant No. 144300510019).

Abstract:

Previous study has shown that 10-hydroxycamptothecin (HCPT) has well-established pharmacological effectsin vitro. However, its in vivo bioavailability is very poor due to various problems, which severely restricts its clinical applications. In the present study, phospholipid complex (PC) technology was employed to improve the solubility and bioavailability of HCPT. XRD data confirmed the formation of HCPT-PC. However, our previously prepared HCPT-PC is too sticky, which may result in the slow dissolution rate and negative effects on its absorption. Therefore, we prepared HCPT-PC-solid dispersion (HCPT-PC-SD) and lipid-based formulations of HCPT-PC through simple preparation process. The results showed that the dissolution rate of HCPT-PC was effectively improved by solid dispersion technology, which reached 91.73% in 45 min. Pharmacokinetic study revealed that the AUC0t of HCPT-PC-SD and HCPT-PC lipid-based formulations was effectively further increased compared with HCPT-PC. Moreover, we found that the combination of SD technology and lipid-base formulations could be a promising drug-delivery system to improve the oral bioavailability of HCPT-PC. In addition, we showed that the bioavailability of HCPT-PC lipid-base formulations was even greater than that of HCPT-PC-SD. In particular, lipid-base formulations could be prepared just by a simple method, suggesting its feasibility of industrialization.

Key words: 10-Hydroxycamptothecin, Phospholipid complex, Solid dispersion, Lipid-based formulations, Bioavailability

CLC Number: 

Supporting: